Skip to content
home-slider-1

Fighting COVID-19

home-slider-2

Rejecting
the “Not Invented Here”

home-slider-3

Working Hard on Treatments
Addressing Unmet
Medical Needs

Pharmaceutical Research Helping Patients & their Families

Ingenew Pharma, a biopharmaceutical company focused on addressing unmet medical needs and serving patients and families affected by serious and debilitating illness. Its primary therapeutic areas of interest include oncology, neurology, urology and dermatology. Ingenew’s current research and development efforts are evaluating proprietary preparations and delivery systems designed to improve the clinical efficacy, reduce toxicity and side effects associated with standard of care.

Research and Development Activities

At Ingenew Pharma we leverage the extensive and successful track record of our scientists and apply adaptive-creative research & development principles to advance tangible and affordable medical solutions.

COVID-19

Hesperidin
SARS-Cov-2

Oncology

Glioblastoma multiform
Basal and Squamous Cell Carcinoma
Melanoma

Dermatology

Atopic Dermatitis / Ezcema
Actinic Keratosis
Basal and Squamous Cell Carcinoma
Melanoma

Urology

Interstitial cystitis /
Bladder Pain Syndrome

Central Nervous System

Glioblastoma multiform
Neurodegenerative disease

Drug Delivery Systems

Licence agreement with Ortho

business development
Partner of choice in developing promising therapeutics and medical solutions.

Products Technologies

We’re working hard on new solutions to help those who are suffering from serious illness.

press release

Ortho Regenerative Technologies Enters Into Licensing Agreement To Expand The Scope Of Its Technological Platform Applications